Cremieux

speaker

21 appearances 1 recordings 1 series first heard Apr 2026 last heard 29 Apr

Cremieux’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Apr 2026 with 1.

Appearances

newest first · ▶ plays the moment

The a16z Show · The Shift in Global Drug Development · 29 Apr 2026 podcast

What happens when the United States is no longer the leader in biomedical innovation?

For decades, the U.S.

dominated drug development, producing a large share of the world's new therapies and setting the pace for clinical research.

But over the last few years, that's started to change.

China has rapidly expanded its clinical trial system, accelerated approvals, and is now leading in both volume and novel drug development.

This shift isn't about scale.

It's about systems.

Regulatory design, trial structure, funding models, and incentives all shape how quickly new treatments reach patients and where innovation happens.

The question now is whether the U.S.

can adapt or whether the center of gravity for biotech continues to move.

Theo Jaffe and Gabriel Dickinson speak with CREMIU.

Sure.

Thanks for listening to this episode of the A16Z podcast.

If you liked this episode, be sure to like, comment, subscribe, leave us a rating or review, and share it with your friends and family.

For more episodes, go to YouTube, Apple Podcasts, and Spotify.

Thanks again for listening, and I'll see you in the next episode.

This information is for educational purposes only and is not a recommendation to buy, hold or sell any investment or financial product.

This podcast has been produced by a third party and may include paid promotional advertisements, other company references and individuals unaffiliated with A16Z.

Such advertisements, companies and individuals are not endorsed by AH Capital Management LLC, A16Z or any of its affiliates.

Showing 1–20 of 21 · page 1 of 2